Alectinib Enhances CAR T-Cell Attack in ALK Neuroblastoma
In the relentless pursuit of breakthroughs in pediatric oncology, a promising frontier has emerged involving the intersection of molecular targeted therapies and immunotherapy. Neuroblastoma (NB),...
















